Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%) : [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"]

Show full item record



Permalink

http://hdl.handle.net/10138/42534

Citation

Hemilä , H 2013 , ' Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%) : [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"] ' , Cochrane database of systematic reviews , no. CD008965 , pp. 271-272 . https://doi.org/10.1002/14651858.CD008965.pub3

Title: Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%) : [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"]
Author: Hemilä, Harri
Contributor: University of Helsinki, Department of Public Health
Date: 2013
Language: eng
Number of pages: 2
Belongs to series: Cochrane database of systematic reviews
ISSN: 1469-493X
URI: http://hdl.handle.net/10138/42534
Abstract: Feedback to the following Cochrane review: Jefferson T, et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965 http://www.ncbi.nlm.nih.gov/pubmed/22258996
Subject: 3111 Biomedicine
317 Pharmacy
Influenza
zinc lozenges
vitamin C
Oseltamivir
Tamiflu
Antiviral Agents
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Hemila_2013_Oseltamivir_Effect.pdf 49.83Kb PDF View/Open
2014_Hemila_Tamiflu_Feedback.pdf 150.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record